NEW YORK, April 30, 2013 /PRNewswire/ -- Diaceutics Limited, a leading personalized healthcare consultancy, and CAHG, a leading professional healthcare communications company, today announced a strategic partnership to develop marketing campaigns specific to personalized healthcare. This value-enhancing marketing service will enable pharmaceutical companies to comprehensively plan and execute global marketing campaigns relevant to targeted therapy and molecular diagnostics.
"The strategic alliance with Diaceutics fits with our overall goal to accelerate the adoption of personalized healthcare into clinical practice," said Scott Cotherman, President and CEO, CAHG and Chairman, TBWA\WorldHealth. "Together we can offer strategies and tactical implementation, from consulting through communication, to help clients realize the promise of personalized healthcare for all stakeholders. Our joint services will be available in the second quarter of 2013."
Diaceutics and CAHG joined forces over the last 12 months to identify clinical and communication gaps, as well as the opportunities arising in the emerging personalized healthcare field. A recently completed study with 400 physicians in the U.S. and EU conducted by CAHG and the Adelphi Group illustrates the opportunity to re-engineer the traditional approach to pharmaceutical marketing and integrate it with the value proposition of personalized healthcare to improve clinical outcomes.
"We are delighted to partner with CAHG, leverage their marketing expertise, and in turn help our pharmaceutical and diagnostic clients create personalized healthcare-specific brands," said Peter Keeling, CEO, Diaceutics. "Personalized healthcare marketing brings its own unique set of challenges in terms of education and multiple stakeholder involvement. However, we believe this represents a significant opportunity for our clients to take a fresh approach to pharmaceutical marketing, away from the one-size-fits-all message towards educational programs that aid the patient journey and help physicians select the tests and treatments best suited to those patients. The right treatment for the right patient begins with the right knowledge."
Diaceutics is an international change management and consulting and services firm specializing in personalized medicine. Diaceutics mission is to build bridges between pharmaceutical and diagnostic companies and to provide pharmaceutical industry leaders with the foundation and operational structure necessary to effectively develop and commercialize targeted therapies that better meet patients' needs and improve return on investment. For more information, visit www.diaceutics.com.
CAHG (www.cahg.com) is one of the largest healthcare communications companies in the world. CAHG provides brand acceleration services throughout the brand's life cycle, from compound development to patent expiry and beyond through the following practice disciplines: professional healthcare advertising and promotion; genomics-based medicine and personalized healthcare strategy and communications; clinical trial patient enrollment and management; scientific insight and solutions; multichannel brand building; managed markets; evolving media and analytics; full-service digital/interactive support and eMarketing solutions; and technology-inspired studio solutions.
CAHG is a part of Diversified Agency Services, a division of Omnicom Group Inc., and is the lead U.S. agency within the TBWA\WorldHealth global network of marketing communications firms.
About Diversified Agency Services
Diversified Agency Services (DAS), a division of Omnicom Group Inc. (NYSE:OMC) (www.omnicomgroup.com), manages Omnicom's holdings in a variety of marketing communications disciplines. DAS includes over 200 companies, which operate through a combination of networks and regional organizations, serving international and local clients through more than 700 offices in 71 countries.
About Omnicom Group Inc.
Omnicom Group Inc. (www.omnicomgroup.com) is a leading global marketing and corporate communications company. Omnicom's branded networks and numerous specialty firms provide advertising, strategic media planning and buying, digital and interactive marketing, direct and promotional marketing, public relations and other specialty communications services to over 5,000 clients in more than 100 countries.
For EU Diaceutics: Sanna Paakkonen, Managing Director, +358 408418283, [email protected] Regional Development Centre, Dundalk Institute of Technology, Dublin Road, Dundalk, Ireland
For U.S. Diaceutics: Mark Reis, Executive Vice President of Business Development and Marketing, 347-708-2223, [email protected] Regional Development Centre, Dundalk Institute of Technology, Dublin Road, Dundalk, Ireland
For CAHG: Suri Harris, EVP, Strategic Planning and New Ventures, 646-428-8918, [email protected] CAHG, 211 E. Chicago Avenue, Chicago, IL 60611 / 220 E. 42nd Street, New York, NY 10017